Lead investigator of The VITAL Rhythm Trial, Dr Christine M Albert (Cedar-Sinai, Los Angeles, CA, US) discusses the results of the study with Dr Harriette Van Spall (McMaster University, Hamilton, CA).

Results from the VITamin D and OmegA-3 TriaL showed that these supplements are not showing benefits for the primary prevention of A-fib patients without a history of CV or cancer.

Recorded remotely from Los Angeles and Hamilton, 2020.

Recording Editor: Michael Knight
Editor: Mirjam Boros